Nuvation Bio Inc. (NUVB) Institutional Ownership

Ownership Summary

Nuvation Bio Inc. (NYSE:NUVB) is held by 216 institutional investors per 13F filings through December 2025.

• Their combined ownership stood at 63.2% of outstanding shares in December 2025, down from 64.8% in September 2025.
• They increased total shares held in Nuvation Bio by 2.26% from the prior quarter, while the number of investors in NUVB increased 36.71% year over year.
• During the quarter, 123 of these 216 funds increased positions in NUVB, 69 reduced exposure, and 24 held steady.
• The aggregate institutional position in Nuvation Bio amounted to 216.56Mn shares as of December 2025, up by 4.79Mn shares quarter on quarter, and up 17.05Mn shares year over year.
• FMR LLC leads ownership in NUVB with 51.42Mn shares as of December 31, 2025, equal to 15.02% of outstanding shares.
• The largest buyers of Nuvation Bio for the quarter ending December 2025 were Laurion Capital Management LP (6.0Mn), Bank Of America Corp /De/ (2.55Mn), Capricorn Fund Managers Ltd (1.59Mn), Qube Research & Technologies Ltd (1.28Mn), SymBiosis Capital Partners, LLC (1.25Mn).
• The largest sellers of Nuvation Bio for the quarter ending December 2025 were MILLENNIUM MANAGEMENT LLC (4.14Mn), CITADEL ADVISORS LLC (2.17Mn), JANE STREET GROUP, LLC (1.79Mn), Nuveen, LLC (1.71Mn), TWO SIGMA INVESTMENTS, LP (1.64Mn).
• Nuvation Bio's 10 largest shareholders as of December 2025 include FMR LLC (51.42Mn), Decheng Capital LLC (25.95Mn), BlackRock, Inc. (24.67Mn), Laurion Capital Management LP (15.71Mn), VANGUARD GROUP INC (15.56Mn), Omega Fund Management, LLC (8.08Mn), State Street Corp (5.86Mn), GEODE CAPITAL MANAGEMENT, LLC (5.71Mn), TANG CAPITAL MANAGEMENT LLC (3.86Mn), ABRAMS CAPITAL MANAGEMENT, L.P. (3.81Mn) per Business Quant data.